Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer

NCT04293419 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Durvalumab (MEDI4736)

Sponsor

Grupo Espanol Multidisciplinario del Cancer Digestivo

Collaborators

[object Object]
[object Object]